A correlation study of the expression of HA-CD44st and HER-2 in breast cancer

References

• Orian-RousseauVCD44 acts as a signaling platform controlling tumor progression and metastasisFront Immunol2015615425904917
   PubMed Web of Science ®Google Scholar
• ThorneRFLeggJWIsackeCMThe role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling eventsJ Cell Sci2004117Pt 337338014702383
   PubMed Web of Science ®Google Scholar
• FangXJJiangHZhaoXPJiangWMThe role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7BMC Cancer20111129021749678
   PubMed Web of Science ®Google Scholar
• FangXJJiangHZhuYQZhangLYFanQHTianYDoxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cellsOncol Rep20143162735274224715151
   PubMed Web of Science ®Google Scholar
• RojasAPadidamMCressDGradyWMTGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-betaBiochim Biophys Acta2009179371165117319339207
   PubMed Web of Science ®Google Scholar
• PannuJGore-HyerEYamanakaMAn increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in sclerodermaArthritis Rheum20045051566157715146427
   PubMed Web of Science ®Google Scholar
• WakefieldLMRobertsABTGF-beta signaling: positive and negative effects on tumorigenesisCurr Opin Genet Dev2002121222911790550
   PubMed Web of Science ®Google Scholar
• RobertsonIBHoriguchiMZilberbergLDabovicBHadjiolovaKRifkinDBLatent TGF-β-binding proteinsMatrix Biol201547445325960419
   PubMed Web of Science ®Google Scholar
• MeranSLuoDDSimpsonRHyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interactionJ Biol Chem201128620176181763021454519
   PubMed Web of Science ®Google Scholar
• OuhtitAMadaniSGuptaITGF-β2: a novel target of CD44-promoted breast cancer invasionJ Cancer20134756657223983821
   PubMed Web of Science ®Google Scholar
• KalluriRWeinbergRAThe basics of epithelial-mesenchymal transitionJ Clin Invest200911961420142819487818
   PubMed Web of Science ®Google Scholar
• PuisieuxABrabletzTCaramelJOncogenic roles of EMT-inducing transcription factorsNat Cell Biol201416648849424875735
   PubMed Web of Science ®Google Scholar
• ZhangYENon-Smad pathways in TGF-beta signalingCell Res200919112813919114990
   PubMed Web of Science ®Google Scholar
• HeldinCHMiyazonoKten DijkePTGF-beta signalling from cell membrane to nucleus through SMAD proteinsNature199739066594654719393997
   PubMed Web of Science ®Google Scholar
• SlamonDJClarkGMWongSGLevinWJUllrichAMcGuireWLHuman breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogeneScience198723547851771823798106
   PubMed Web of Science ®Google Scholar
• YuQZhuZLiuYZhangJLiKEfficacy and safety of HER2-targeted agents for breast cancer with HER2-overexpression: a network meta-analysisPLoS One2015105e012740425993646
   PubMed Web of Science ®Google Scholar
• Del MastroLLambertiniMBighinCTrastuzumab as first-line therapy in HER2-positive metastatic breast cancer patientsExpert Rev Anticancer Ther201212111391140523072512
   PubMed Web of Science ®Google Scholar
• GhatakSMisraSTooleBPHyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cellsJ Biol Chem2005280108875888315632176
   PubMed Web of Science ®Google Scholar
• BourguignonLYZhuHZhouBDiedrichFSingletonPAHungMCHyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growthJ Biol Chem200127652486794869211606575
   PubMed Web of Science ®Google Scholar
• BoulbesDRChauhanGBJinQBartholomeuszCEstevaFJCD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cellsBreast Cancer Res Treat2015151350151325971596
   PubMed Web of Science ®Google Scholar
• LiLQiLLiangZTransforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cellsInt J Mol Med201536111312226005723
   PubMed Web of Science ®Google Scholar
• QuanJElhousinyMJohnsonNWGaoJTransforming growth factor-β1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteo-clastsClin Exp Metastasis201330565967023378237
   PubMed Web of Science ®Google Scholar
• HaidarMWhitworthJNoéGLiuWQVidalMLangsleyGTGF-β2 induces Grb2 to recruit PI3-K to TGF-RII that activates JNK/AP-1-signaling and augments invasiveness of Theileria-transformed macrophagesSci Rep201551568826511382
   PubMed Web of Science ®Google Scholar
• O’BrienSiobhan KChenLZhongWBreast cancer cells respond differentially to modulation of TGF-β2 signaling after exposure to chemotherapy or hypoxiaCancer Res201575214605461626340918
   PubMed Web of Science ®Google Scholar
• DoTVKubbaLADuHSturgisCDWoodruffTKTransforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transitionMol Cancer Res20086569570518505915
   PubMed Web of Science ®Google Scholar
• ZhangCZhangFTsanRFidlerIJTransforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brainCancer Res200969382883519141644
   PubMed Web of Science ®Google Scholar
• HilbigAOettleHTransforming growth factor beta in pancreatic cancerCurr Pharm Biotechnol201112122158216421619533
   PubMed Web of Science ®Google Scholar
• DaviesMPrimeSSEvesonJWTransforming growth factor-β enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytesInt J Exp Pathol201293214815622414291
   PubMed Web of Science ®Google Scholar
• NamKOhSLeeKMYooSAShinICD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cellsCell Signal20152791882189425979842
   PubMed Web of Science ®Google Scholar
• ChekhunSVZadvornyTVTymovskaYOAnikuskoMFNovakOEPolishchukLZCD44+/CD24-markers of cancer stem cells in patients with breast cancer of different molecular subtypesExp Oncol2015371586325804234
   PubMedGoogle Scholar
• SeoANLeeHJKimEJExpression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancerBr J Cancer2016114101109111627115469
   PubMed Web of Science ®Google Scholar
• QiuYPuTGuoPALDH(+)/CD44(+) cells in breast cancer are associated with worse prognosis and poor clinical outcomeExp Mol Pathol2016100114515026687806
   PubMed Web of Science ®Google Scholar
• ZhengZShaoNWengHCorrelation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinomaMed Oncol201532127525429827
   PubMed Web of Science ®Google Scholar
• BaekJMJinQEnsorJBoulbesDREstevaFJSerum CD44 levels and overall survival in patients with HER2-positive breast cancerBreast Cancer Res Treat201113031029103621830016
   PubMed Web of Science ®Google Scholar
• BellerbyRSmithCKymeSOverexpression of specific CD44 isoforms is associated with aggressive cell features in acquired endocrine resistanceFront Oncol2016614527379207
   PubMed Web of Science ®Google Scholar
• AuvinenPTammiRKosmaMIncreased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancerInt J Cancer2013132353153922753277
   PubMed Web of Science ®Google Scholar
• InoueKFryEAAberrant splicing of estrogen receptor, HER2, and CD44 genes in breast cancerGenet Epigenet20157193226692764
   PubMed Web of Science ®Google Scholar
• OlssonEHonethGBendahlPOCD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markersBMC Cancer20111141821957977
   PubMed Web of Science ®Google Scholar